Logo

Bio-Techne

Bio-Techne, Carterra Partner on COVID-19 Variant Analysis

The firms are developing a high-throughput, scalable assay for the screening and characterization of SARS-CoV-2 spike and receptor-binding domain variants.

Bio-Techne Q4 Revenues Jump 47 Percent

The firm's Diagnostics and Genomics revenues rose 38 percent to $67.1 million for the fourth quarter and rose 23 percent to $227.7 million for fiscal 2021.

New Products Posted to GenomeWeb: SpeeDx, Bio-Techne, NuProbe, More

Bio-Techne Fiscal Q3 Revenues Rise 25 Percent as End Markets Improve

Its ProteinSimple proteomic analytical tools and Advanced Cell Diagnostics tissue biopsy products were standouts in the quarter, Bio-Techne's CEO said.

New Products Posted to GenomeWeb: Pacific Biosciences, Paragon Genomics, Bio-Techne, More

Apr 9, 2021

In Brief This Week: Bio-Techne, Dante Labs, Metagenomi, Applied DNA Sciences, Caris Life Sciences

Mar 23, 2021

Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test

Mar 17, 2021

Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy
Premium

Mar 3, 2021

Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

Mar 1, 2021

Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test

Feb 2, 2021

Bio-Techne Fiscal Q2 Revenues Rise 21 Percent

Jan 14, 2021

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Dec 2, 2020

Bio-Techne, Regulus Therapeutics to Develop Assays for Kidney Disease Treatment

Nov 5, 2020

Bio-Techne Fiscal Q1 Revenues Rise 11 Percent on Diagnostics and Genomics Sales

Sep 17, 2020

Bio-Techne, Qiagen Expand Partnership on Exosome Technology

Aug 24, 2020

Inflammatory Cytokine Biomarkers Predict COVID-19 Survival, Could Yield Dx, Rx Targets

Aug 21, 2020

New Products Posted to GenomeWeb: Thermo Fisher, Qiagen, Bio-Techne, More

Aug 4, 2020

Bio-Techne Q4 Revenues Drop 8 Percent

Jun 12, 2020

In Brief This Week: Guardant Health, Illumina, Twist Bioscience, Hologic, InCellDx, More

May 26, 2020

Bio-Techne, Leica Biosystems Receive CE Mark for Pathology Detection Kit, Platform

May 20, 2020

Bio-Techne Bets Clinical Utility Study Data Will Sway Payors to Cover Prostate Cancer Risk Test
Premium

Apr 30, 2020

Bio-Techne Fiscal Q3 Revenues Rise 5 Percent Despite Coronavirus Challenges

Mar 18, 2020

Bio-Techne Lands Government Contract for Genomic Prostate Cancer Test

Feb 4, 2020

Bio-Techne FY Q2 Revenues Rise 6 Percent, Miss Analysts' Estimate

Oct 29, 2019

Bio-Techne Fiscal Q1 Revenues Rise 12 Percent

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.